The development and validation of an UHPLC–MS/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The development and validation of an UHPLC–MS/MS method for the rapid quantification of the antiretroviral agent dapivirine in human plasma
Authors
Keywords
-
Journal
Bioanalysis
Volume 5, Issue 22, Pages 2771-2783
Publisher
Future Science, LTD
Online
2013-11-21
DOI
10.4155/bio.13.256
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiviral agents and HIV prevention
- (2012) Myron S. Cohen et al. AIDS
- Development and validation of a HPLC method for the assay of dapivirine in cell-based and tissue permeability experiments
- (2012) José das Neves et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana
- (2012) Michael C. Thigpen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
- (2012) Jared M. Baeten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preexposure Prophylaxis for HIV Infection among African Women
- (2012) Lut Van Damme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination
- (2011) Susan M. Schader et al. AIDS
- Development and characterization of a vaginal film containing dapivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), for prevention of HIV-1 sexual transmission
- (2011) Ayman Akil et al. Drug Delivery and Translational Research
- Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission
- (2010) Jonathan Weber et al. AIDS
- Pharmacokinetic Assessment of Dapivirine Vaginal Microbicide Gel in Healthy, HIV-Negative Women
- (2010) Annalene M. Nel et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Pharmacokinetics of 2 Dapivirine Vaginal Microbicide Gels and Their Safety Vs. Hydroxyethyl Cellulose-Based Universal Placebo Gel
- (2010) Annalene M Nel et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Development and validation of a rapid reversed-phase HPLC method for the determination of the non-nucleoside reverse transcriptase inhibitor dapivirine from polymeric nanoparticles
- (2010) José das Neves et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women
- (2009) Annalene M Nel et al. AIDS
- Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring
- (2009) J. Romano et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Safety and Pharmacokinetics of Dapivirine Delivery From Matrix and Reservoir Intravaginal Rings to HIV-Negative Women
- (2009) Annalene Nel et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Inhibition of Human Immunodeficiency Virus Type 1 Infection by the Candidate Microbicide Dapivirine, a Nonnucleoside Reverse Transcriptase Inhibitor
- (2008) P. Fletcher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now